Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PAVmed (PAVM) Change in Account Payables (2021 - 2025)

PAVmed (PAVM) has 5 years of Change in Account Payables data on record, last reported at -$47000.0 in Q3 2025.

  • For Q3 2025, Change in Account Payables changed N/A year-over-year to -$47000.0; the TTM value through Sep 2025 reached -$125000.0, changed N/A, while the annual FY2024 figure was -$59000.0, 93.57% up from the prior year.
  • Change in Account Payables reached -$47000.0 in Q3 2025 per PAVM's latest filing, down from $18000.0 in the prior quarter.
  • Across five years, Change in Account Payables topped out at $3.9 million in Q1 2022 and bottomed at -$2.9 million in Q2 2022.
  • Average Change in Account Payables over 5 years is -$120222.2, with a median of -$174500.0 recorded in 2023.
  • The widest YoY moves for Change in Account Payables: up 466.54% in 2022, down 266.57% in 2022.
  • A 5-year view of Change in Account Payables shows it stood at -$2.7 million in 2021, then surged by 108.73% to $239000.0 in 2022, then crashed by 259.0% to -$380000.0 in 2023, then skyrocketed by 150.0% to $190000.0 in 2024, then crashed by 124.74% to -$47000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Account Payables were -$47000.0 in Q3 2025, $18000.0 in Q2 2025, and -$286000.0 in Q1 2025.